Pursuant to Regulation 30 read with sub para 15, Para A Part A Schedule III of the Securities and Exchange Board of India Listing Obligations and Disclosure Requirements) Regulations, 2015, ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fredun Pharmaceuticals has informed the stock exchanges that it will host an earnings conference call on Friday, 1st August 2025 at 11:00 a.m. The call will follow the announcement of financial results for the quarter ended 30th June 2025 (Q1 FY2026). Investors and analysts can join via the provided Chorus Call registration link or by dialling in on the listed numbers. The disclosure has been made under SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015, and signed by Managing Director Fredun Medhora. The BSE scrip code for the company is 539730.
This is a routine pre-results disclosure inviting investors and analysts to hear management discuss the just-concluded quarter's performance. The call itself may offer forward-looking commentary on revenue, margins, and business outlook, which could move the stock once the results and management views are made public.